StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) shareholders

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1.7%
0M of 4M shares
Institutional holders
6
6 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
3 buys · 3 sales
Net bought $8.41K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Scablis AG581,9387.00%13G (passive)Sep 24, 2024
New Horizon Health Limited573,0806.91%13G (passive)Sep 24, 2024
Fredric Zaino
Joint filing with Keystone Capital Partners, LLC (6.32%), RANZ Group LLC (6.32%)
419,2986.32%13G (passive) amendmentSep 30, 2026
Altos Venture AG273,23035.80%13D (active) amendmentJul 14, 2025
Keystone Capital Partners, LLC
Joint filing with RANZ Group LLC (6.10%), Fredric Zaino (6.10%)
223,7176.10%13G (passive)Jul 20, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ONCOValueChange% of portfolio
Hrt Financial LP51,3981.30%$58.00KNew0.00%
XTX Topco Ltd13,5480.34%$15.31KNew0.00%
SBI Securities Co., Ltd.2520.01%$285New0.00%
Tower Research Capital LLC (TRC)1450.00%$164New0.00%
Hollencrest Capital Management1000.00%$113New0.00%
Morgan Stanley210.00%$24New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202660M1.7%6 / 00 / 00M0M
Q1 202600M0.0%0 / 00 / 70M0M
Q4 202570M0.0%1 / 21 / 20M0M
Q3 202580M0.0%3 / 30 / 20M0M
Q2 202570M0.0%1 / 40 / 70M0M
Q1 2025130M0.0%5 / 13 / 30M0M
Q4 2024110M0.0%4 / 13 / 10M0M
Q3 202480M0.0%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

2 funds held ONCO in Q1 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ONCOValue% of fundAs of
Fidelity Extended Market Index Fund1,1720.03%$1.41K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David Allan WhiteChief Executive Officer––Mar 27, 2026
Christian BruhlmannChief Strategy Officer611,37215.48%Jan 22, 2025
Ralph SchiessInterim CEO, CSO673,36517.05%Jan 22, 2025
Sammy DorfDirector––Mar 27, 2026
Sarah RomanoDirector––Dec 12, 2025
Andrew John OakleyDirector6380.02%Aug 19, 2025
Simon TarshDirector400.00%Aug 19, 2025
Timothy R. RamdeenDirector400.00%Aug 19, 2025
Thomas MeierDirector390.00%Aug 19, 2025
Financial Lp Hrt10% owner33,6490.85%Apr 22, 2026
Venture AG Altos10% owner273,2306.92%Jul 16, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Financial Lp Hrt
10% owner
Apr 21, 2026Sale−49,710$0.69$34.30K33,649
Financial Lp Hrt
10% owner
Apr 20, 2026Sale−94,462$0.75$70.85K83,359
Financial Lp Hrt
10% owner
Apr 17, 2026Buy+34,636$0.73$25.28K177,821
Financial Lp Hrt
10% owner
Apr 16, 2026Sale−53,867$0.73$39.32K143,185
Financial Lp Hrt
10% owner
Apr 15, 2026Buy+92,554$0.76$70.34K197,052
Financial Lp Hrt
10% owner
Apr 14, 2026Buy+74,350$0.77$57.25K104,498
Timothy R. Ramdeen
Director
Aug 15, 2025Other+39––40
Timothy R. Ramdeen
Director
Aug 15, 2025Award+618––658
Andrew John Oakley
Director
Aug 15, 2025Award+618––638
Andrew John Oakley
Director
Aug 15, 2025Other+20––20
Thomas Meier
Director
Aug 15, 2025Other+39––39
Thomas Meier
Director
Aug 15, 2025Award+618––657
Simon Tarsh
Director
Aug 15, 2025Other+39––40
Simon Tarsh
Director
Aug 15, 2025Award+618––658
Venture AG Altos
10% owner
Jul 14, 2025Other+241,514––273,230
Andrew John Oakley
Director
Mar 23, 2025Award+1,709––1,709
Christian Bruhlmann
Chief Strategy Officer
Dec 20, 2024Award+177,462––611,372
Ralph Schiess
Interim CEO, CSO
Dec 20, 2024Award+177,462––673,365
Timothy R. Ramdeen
Director
Sep 26, 2024Award+3,318––3,477
Simon Tarsh
Director
Sep 26, 2024Award+3,318––3,477
James Sapirstein
Director
Sep 26, 2024Award+3,318––3,477
Thomas Meier
Director
Sep 26, 2024Award+3,318––3,318
Ajit Singh
Director
Sep 26, 2024Award+3,318––3,396
Ralph Schiess
Interim CEO & CSO
Sep 24, 2024Award+489,160––495,903
Christian Bruhlmann
Chief Strategy Officer
Sep 24, 2024Award+428,010––433,910
Ajit Singh
Director
Feb 16, 2024Award+3,125––3,125
Vuk Jeremic
Director
May 31, 2023Award+6,360––6,360
James Sapirstein
Director
May 31, 2023Award+6,360––6,360
Simon Tarsh
Director
May 31, 2023Award+6,360––6,360
Timothy R. Ramdeen
Director
May 31, 2023Award+6,360––6,360
Jon Garfield
Chief Financial Officer
May 9, 2023Award+100,000––100,000
Erin Henderson
Chief Business Officer
May 9, 2023Award+150,000––174,752
Joseph Hernandez
CEO, Director, 10% owner
May 9, 2023Award+150,000––2,800,351
Cincinnati Cornerstone Investors BWV I, LLC
10% owner
Apr 10, 2023Other−1,200,000––1,161,201
Cincinnati Cornerstone Investors BWV I, LLC
10% owner
Nov 17, 2022Other−750,000––2,361,201
Cornerstone Capital LLC Cincinnati
–
Aug 25, 2022Other−500,000––3,111,201
Joseph Hernandez
CEO, Director, 10% owner
Aug 22, 2022Sale−30,269$4.10$124.10K2,650,351
Allan Shaw
Director
Aug 19, 2022Tax withholding+29,636$0.01$29629,636
Allan Shaw
Director
Aug 19, 2022Sale−29,636$3.94$116.77K0
Joseph Hernandez
CEO, Director, 10% owner
Aug 19, 2022Sale−76,841$4.21$323.50K2,680,620
Erin Henderson
Chief Business Officer
Aug 19, 2022Tax withholding+4,834$0.01$4829,586
Erin Henderson
Chief Business Officer
Aug 19, 2022Sale−4,834$3.97$19.19K24,752
Joseph Hernandez
CEO, Director, 10% owner
Aug 18, 2022Sale−442,539$4.96$2.19M2,757,461
Erin Henderson
Chief Business Officer
Aug 18, 2022Tax withholding+24,752$0.01$24824,752
Cincinnati Cornerstone Investors BWV I, LLC
10% owner
Feb 23, 2022Conversion+3,611,201––3,611,201

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
40.63%
1M shares short
Days to cover
1.0
At 5M shares a day
Change since last report
+145.6%
From 0M shares
Short volume, 20 days
57.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Onconetix's stock actually held short. Settlement fails (shares not delivered on time) peaked at 702,079 shares on Oct 9, 2026 over the last 90 days.

See a number that looks wrong?